PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-0.77%
Revenue decline while CRWD shows 5.94% growth. Joel Greenblatt would examine competitive position erosion.
8.93%
Cost growth 1.1-1.25x CRWD's 7.31%. Bill Ackman would demand evidence of cost control initiatives.
-5.44%
Gross profit decline while CRWD shows 5.45% growth. Joel Greenblatt would examine competitive position.
-4.70%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-1.86%
R&D reduction while CRWD shows 3.75% growth. Joel Greenblatt would examine competitive risk.
-16.17%
G&A reduction while CRWD shows 7.72% growth. Joel Greenblatt would examine efficiency advantage.
-20.38%
Marketing expense reduction while CRWD shows 1.68% growth. Joel Greenblatt would examine competitive risk.
46.97%
Other expenses change of 46.97% while CRWD maintains costs. Bruce Berkowitz would investigate efficiency.
-13.45%
Operating expenses reduction while CRWD shows 3.48% growth. Joel Greenblatt would examine advantage.
-3.31%
Total costs reduction while CRWD shows 4.38% growth. Joel Greenblatt would examine advantage.
-4.73%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-18.03%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-11.82%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
1.90%
EBITDA margin growth while CRWD declines. John Neff would investigate advantages.
-9.84%
Operating income decline while CRWD shows 9.37% growth. Joel Greenblatt would examine position.
-9.14%
Operating margin decline while CRWD shows 14.45% growth. Joel Greenblatt would examine position.
-45.26%
Other expenses reduction while CRWD shows 18.80% growth. Joel Greenblatt would examine advantage.
-10.35%
Pre-tax income decline while CRWD shows 20.26% growth. Joel Greenblatt would examine position.
-9.65%
Pre-tax margin decline while CRWD shows 24.73% growth. Joel Greenblatt would examine position.
-30.99%
Both companies reducing tax expense. Martin Whitman would check patterns.
-1.56%
Net income decline while CRWD shows 29.52% growth. Joel Greenblatt would examine position.
-0.79%
Net margin decline while CRWD shows 33.47% growth. Joel Greenblatt would examine position.
-1.79%
EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-1.82%
Diluted EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
0.04%
Share count reduction exceeding 1.5x CRWD's 0.59%. David Dodd would verify capital allocation.
0.07%
Diluted share reduction exceeding 1.5x CRWD's 0.59%. David Dodd would verify capital allocation.